Jeffrey R. Schneider, PhD

Biography

Jeffrey R. Schneider, PhD’s lab focuses on HIV antibody distribution. He has helped develop a platform to track intravenous injected fluorophore conjugated IgG in plasma, tissue, and weck-cel fluid. This methodology has led to a grant to study how the timing of antibody injection affects distal site accumulation of virus following challenge. Through a better understanding of how antibodies get to and fortify mucosal surfaces from incoming pathogens, this research has the potential to elucidate novel HIV prevention strategies with the ultimate goal of blocking initial HIV transmission. This work will help inform future passive immunization studies, such as the AMP (Antibody Mediated Prevention) trial which is currently underway and administering anti-HIV antibodies to at-risk individuals around the world. As the SARS-CoV-2 pandemic emerged, Schneider has adapted his work with HIV antibodies to better understand the neutralizing antibody response in COVID-19 patients.

Honors and Activities

2011 Biological Science Travel Award, University of Chicago Division of Biological Sciences
2014 Scholarship Recipient, HIV R4P Research for Prevention
2014 Session Chair and Scholarship Recipient, Keystone Symposia on HIV Vaccines
2014 HIV Research for Prevention Scholarship Recipient, Cape Town, South Africa
2015 CAVD Exchange Award, Bill and Melinda Gates Foundation
2016 Northwestern University Office of Post-doctoral Affairs Travel Award
2016 International AIDS Conference Scholarship Recipient, Durban, South Africa
2016 International AIDS Conference, Rapporteur-Basic Track, Durban, South Africa
2016 HIV Research for Prevention Scholarship Recipient, Chicago, USA

Publications

Complete list of published work on PubMed
Complete list of published work on Scopus

Grants

NIH K01OD024882: “The role of steady state broadly neutralizing antibody tissue levels in preventing distal site SHIV replication”
NIH R21MH125339: “Imaging the CNS SIV reservoir in a cART cessation model”
Walder Foundation Grant, “Characterizing the neutralizing antibody response in SARS-CoV-2 infected individuals”
Walder Foundation Grant, “Characterizing the long-term durability and composition of COVID-19 vaccine induced antibodies”
Walder Foundation Grant, “B3: Boosters, Breakthroughs, and Biorepositories”

Education

Research Areas